Ep34: Investing in Digital Health: Justin Norden Shares Insights Into Succeeding in DTx

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden. Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health. In this episode, we cover: The Healthcare Thesis at GSR Ventures Virtual Reality (VR) Digital Therapeutics Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx What it would take to scale existing Prescription Digital Therapeutics The Role Of Health Coaching alongside AI automation The Drivers of Success Going Forward for the Digital Therapeutics Market Guest Links and Resources: Connect with Justin Norden on LinkedIn | Twitter Visit https://gsrventuresglobal.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram